Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 2Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

NIH 4OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Prostatic Intraepithelial Neoplasia 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Lycopene × Clear all
NCT01949519 2018-01-11

Docetaxel and Lycopene in Metastatic Prostate Cancer

Medical University of South Carolina

Phase 1 Completed
24 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00178113 2015-05-27

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

University of Pittsburgh

Phase 1 Completed
80 enrolled
Genitourinary

Prostatic Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡